Chihiro Shimazaki

7.1k total citations · 1 hit paper
213 papers, 4.0k citations indexed

About

Chihiro Shimazaki is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Chihiro Shimazaki has authored 213 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 130 papers in Hematology, 77 papers in Oncology and 66 papers in Molecular Biology. Recurrent topics in Chihiro Shimazaki's work include Multiple Myeloma Research and Treatments (64 papers), Acute Myeloid Leukemia Research (34 papers) and Hematopoietic Stem Cell Transplantation (31 papers). Chihiro Shimazaki is often cited by papers focused on Multiple Myeloma Research and Treatments (64 papers), Acute Myeloid Leukemia Research (34 papers) and Hematopoietic Stem Cell Transplantation (31 papers). Chihiro Shimazaki collaborates with scholars based in Japan, United States and Greece. Chihiro Shimazaki's co-authors include Masao Nakagawa, Tohru Inaba, Eishi Ashihara, Naohisa Fujita, Ryuzo Ueda, Hitoshi Kiyoi, Hidehiko Saito, Kazutaka Kuriyama, Hideyo Hirai and Kenji Saito and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Biochemical and Biophysical Research Communications.

In The Last Decade

Chihiro Shimazaki

205 papers receiving 3.9k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia.

1999 620 citations Chihiro Shimazaki et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chihiro Shimazaki Japan	33	2.4k	1.5k	1.2k	813	659	213	4.0k
Marco Gobbi Italy	33	1.9k 0.8×	1.0k 0.7×	1.3k 1.1×	896 1.1×	969 1.5×	171	3.9k
Shigeo Horiike Japan	31	2.1k 0.9×	1.6k 1.1×	935 0.8×	933 1.1×	550 0.8×	165	4.1k
Stefan Hohaus Italy	39	1.5k 0.6×	1.4k 1.0×	1.4k 1.1×	591 0.7×	913 1.4×	167	4.2k
Paola Ballerini France	31	2.1k 0.9×	2.5k 1.7×	1.4k 1.1×	627 0.8×	564 0.9×	78	4.6k
Lee‐Yung Shih Taiwan	30	1.7k 0.7×	1.2k 0.8×	663 0.5×	776 1.0×	347 0.5×	195	3.6k
Hideaki Mizoguchi Japan	36	1.5k 0.7×	911 0.6×	672 0.6×	683 0.8×	941 1.4×	141	3.5k
Marie‐Thérèse Daniel France	30	1.4k 0.6×	1.2k 0.8×	818 0.7×	499 0.6×	400 0.6×	58	2.8k
Dina Ben‐Yehuda Israel	35	1.7k 0.7×	2.1k 1.4×	1.3k 1.1×	1.2k 1.4×	579 0.9×	124	4.8k
Jean‐Michel Cayuela France	33	2.1k 0.9×	1.0k 0.7×	784 0.6×	837 1.0×	552 0.8×	101	3.8k
DC Arthur United States	25	1.6k 0.7×	754 0.5×	953 0.8×	516 0.6×	512 0.8×	47	3.0k

Countries citing papers authored by Chihiro Shimazaki

Since Specialization

Citations

This map shows the geographic impact of Chihiro Shimazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chihiro Shimazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chihiro Shimazaki more than expected).

Fields of papers citing papers by Chihiro Shimazaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chihiro Shimazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chihiro Shimazaki. The network helps show where Chihiro Shimazaki may publish in the future.

Co-authorship network of co-authors of Chihiro Shimazaki

This figure shows the co-authorship network connecting the top 25 collaborators of Chihiro Shimazaki. A scholar is included among the top collaborators of Chihiro Shimazaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chihiro Shimazaki. Chihiro Shimazaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sunami, Kazutaka, Shin‐ichi Fuchida, Kenshi Suzuki, et al.. (2022). Anti‐CD38 antibody isatuximab monotherapy for Japanese individuals with relapsed/refractory multiple myeloma: An update of the phase 1/2 ISLANDs study. Hematological Oncology. 41(3). 442–452. 1 indexed citations

Iida, Shinsuke, Chihiro Shimazaki, Masahiro Abe, & Chiaki Nakaseko. (2019). JSH practical guidelines for hematological malignancies, 2018: III. Myeloma-2. Related disorders of multiple myeloma. International Journal of Hematology. 109(6). 633–640. 2 indexed citations

Ri, Masaki, Kosei Matsue, Kazutaka Sunami, et al.. (2017). Efficacy and safety of plerixafor for the mobilization/collection of peripheral hematopoietic stem cells for autologous transplantation in Japanese patients with multiple myeloma. International Journal of Hematology. 106(4). 562–572. 14 indexed citations

Kitani, Takashi, Keiichi Tamagaki, Shin‐ichi Fuchida, et al.. (2017). Renal artery stenosis following nilotinib administration in a patient with chronic myelogenous leukemia.. PubMed. 58(1). 15–19.

Kiyota, Miki, Tsutomu Kobayashi, Shin‐ichi Fuchida, et al.. (2012). Monosomy 13 in metaphase spreads is a predictor of poor long-term outcome after bortezomib plus dexamethasone treatment for relapsed/refractory multiple myeloma. International Journal of Hematology. 95(5). 516–526. 10 indexed citations

Murakami, Hirokazu, Kazuyuki Shimizu, Morio Sawamura, et al.. (2009). Phase II and pharmacokinetic study of thalidomide in Japanese patients with relapsed/refractory multiple myeloma. International Journal of Hematology. 89(5). 636–641. 9 indexed citations

Kanbayashi, Yuko, Ken‐ichi Nomura, Yoshiko Fujimoto, et al.. (2008). Population pharmacokinetics of itraconazole solution used as prophylaxis for febrile neutropenia. International Journal of Antimicrobial Agents. 31(5). 452–457. 5 indexed citations

Hatta, Tsuguru, et al.. (2006). Histological analysis on adhesive molecules of renal intravascular large B cell lymphoma treated with CHOP chemotherapy and rituximab. Clinical Nephrology. 65(3). 222–226. 17 indexed citations

Takahashi, Ryoichi, Noriko Yamada, Ryo Uchida, et al.. (2005). Plasmacytoma of the Urinary Bladder in a Renal Transplant Recipient. International Journal of Hematology. 81(3). 255–257. 13 indexed citations

10.

Takahashi, Ryoichi, Chihiro Shimazaki, Tohru Inaba, et al.. (2001). A newly developed bisphosphonate, YM529, is a potent apoptosis inducer of human myeloma cells. Leukemia Research. 25(1). 77–83. 50 indexed citations

11.

Chou, Takaaki, Fumio Kawano, Hisashi Gondo, et al.. (1999). A Multicenter Early Phase II Study of High-dose Chemotherapy with Autologous Peripheral Blood Stem Cell Transplantation for Treatment of Intermediate-grade Non-Hodgkin's Lymphoma.. 40(10). 1058–1067. 7 indexed citations

12.

Yagita, Masato, et al.. (1998). [Extramedullary relapse in the external auditory canal in a patient with acute promyelocytic leukemia treated with all-trans retinoic acid and autologous peripheral blood stem cell transplantation].. PubMed. 39(9). 709–15. 3 indexed citations

13.

Tatsumi, Tetsuya, Chihiro Shimazaki, Shin‐ichi Araki, et al.. (1997). Philadelphia chromosome-positive acute lymphoblastic leukemia after therapy for langerhans cell histiocytosis. American Journal of Hematology. 54(1). 88–88. 8 indexed citations

14.

Satoh, Etsuko, M Osawa, Ki-ichiro Tomiyasu, et al.. (1997). Efficient Gene Transduction by Epstein–Barr-Virus-Based Vectors Coupled with Cationic Liposome and HVJ-Liposome. Biochemical and Biophysical Research Communications. 238(3). 795–799. 28 indexed citations

15.

Tatsumi, Tetsuya, Chihiro Shimazaki, Hideo Goto, et al.. (1996). Expression of Adhesion Molecules on Myeloma Cells. Japanese Journal of Cancer Research. 87(8). 837–842. 36 indexed citations

16.

Goto, Hideo, Chihiro Shimazaki, Toshiyuki Hirata, et al.. (1993). Recombinant Human Granulocyte Colony-Stimulating Factor in Combination with Continuous Infusion of Cytosine Arabinoside for the Treatment of Refractory Acute Myelogenous Leukemia. Acta Haematologica. 89(3). 144–148. 4 indexed citations

17.

Ashihara, Eishi, Chihiro Shimazaki, Toshiyuki Hirata, et al.. (1993). Autoimmune thrombocytopenia following peripheral blood stem cell autografting.. PubMed. 12(3). 297–9. 15 indexed citations

18.

Hara, Junichi, Keiko Yumura‐Yagi, S Tagawa, et al.. (1990). Molecular analysis of T cell receptor and CD3 genes in CD3- large granular lymphocytes (LGLs): evidence for the existence of CD3- LGLs committed to the T cell lineage.. PubMed. 4(8). 580–3. 7 indexed citations

19.

Gotoh, Hideo, Satoshi Murakami, Kunihiko Itoh, et al.. (1988). Translocations t(15;17) and t(9;14)(q34;q22) in a case of acute promyelocytic leukemia with increased number of basophils. Cancer Genetics and Cytogenetics. 36(1). 103–107. 10 indexed citations

20.

Shimazaki, Chihiro, et al.. (1986). Early diagnosis of invasive candidiasis in leukemia : Evaluation of D- arabinitol in serum.:Evaluation of D-Arabinitol in Serum. 27(3). 165–169. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact